COVID-19 vaccines significantly reduce hospital admissions in Scotland

Web Desk. A study in Scotland found that vaccines designed to prevent Covid-19 could significantly reduce hospital admissions rates. In fact, a single dose of the vaccine can reduce hospital admissions by more than 85%.

The study found that hospital admissions in Scotland dropped by 85% after four weeks of using a single dose of Pfizer-BioNTech and Oxford-AstraZeneca vaccines. According to the study, the use of a single dose of the vaccine in people aged 80 and over who are at high risk of the disease reduced the hospitalization rate by 81% by the fourth week.

According to the Scottish Department of Health, this is great news for the vaccine program that is working, and more importantly, vaccines can significantly reduce the burden on hospitals. Both of these vaccines are being used in Scotland.

The AstraZeneca vaccine was used more in the elderly group, and researchers say the vaccine appears to be more effective in the elderly. Only two people in the study who were vaccinated were hospitalized, compared to the Pfizer vaccine users.

Volunteers for both vaccines were given only one dose and the second after the 12 weeks. The results showed that such an interval is better for the AstraZeneca vaccine, but those who used a single dose of the Pfizer vaccine saw an increase in hospital admissions after 21 days. However, this number was not very high and more research is needed at this time.

The study looked at data on dosages of more than 1.1 million vaccines in Scotland between December 8 and February 15, during that time 21 percent of Scotland’s population would receive the first dose. Of these, 650,000 million were given the Pfizer vaccine and 490,000 were given the AstraZeneca vaccine.

The medical. researchers said, The results are very encouraging and allow us to be more optimistic about the future. We now have national evidence that vaccination can significantly reduce the effects of Covid-19.

Seven symptoms that should be considered a Covid-19 test, research

Here at, what matters the most is your valuable engagement and YOU, the readers!